Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
August 31, 2022
The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the